BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36853048)

  • 1. Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in Mice.
    Krug S; Prasad P; Xiao S; Lun S; Ruiz-Bedoya CA; Klunk M; Ordonez AA; Jain SK; Srikrishna G; Kramnik I; Bishai WR
    mBio; 2023 Apr; 14(2):e0349622. PubMed ID: 36853048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas.
    Skerry C; Harper J; Klunk M; Bishai WR; Jain SK
    PLoS One; 2012; 7(6):e39680. PubMed ID: 22761866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas.
    Bhattacharya B; Xiao S; Chatterjee S; Urbanowski M; Ordonez A; Ihms EA; Agrahari G; Lun S; Berland R; Pichugin A; Gao Y; Connor J; Ivanov AR; Yan BS; Kobzik L; Koo BB; Jain S; Bishai W; Kramnik I
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33301427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model.
    Ruelas Castillo J; Neupane P; Karanika S; Krug S; Quijada D; Garcia A; Ayeh S; Yilma A; Costa DL; Sher A; Fotouhi N; Serbina N; Karakousis PC
    Antimicrob Agents Chemother; 2024 Feb; 68(2):e0104323. PubMed ID: 38132181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice.
    Dutta NK; Bruiners N; Zimmerman MD; Tan S; Dartois V; Gennaro ML; Karakousis PC
    J Infect Dis; 2020 Mar; 221(7):1079-1087. PubMed ID: 31605489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis.
    Pahuja I; Verma A; Ghoshal A; Mukhopadhyay S; Kumari A; Shaji A; Chaturvedi S; Dwivedi VP; Bhaskar A
    Microbiol Spectr; 2023 Aug; 11(4):e0085823. PubMed ID: 37272833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor.
    Gupta S; Tyagi S; Almeida DV; Maiga MC; Ammerman NC; Bishai WR
    Am J Respir Crit Care Med; 2013 Sep; 188(5):600-7. PubMed ID: 23805786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T Lymphocytes.
    Costa DL; Namasivayam S; Amaral EP; Arora K; Chao A; Mittereder LR; Maiga M; Boshoff HI; Barry CE; Goulding CW; Andrade BB; Sher A
    mBio; 2016 Oct; 7(5):. PubMed ID: 27795400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin adjunctive therapy shortens the duration of TB treatment in mice.
    Dutta NK; Bruiners N; Pinn ML; Zimmerman MD; Prideaux B; Dartois V; Gennaro ML; Karakousis PC
    J Antimicrob Chemother; 2016 Jun; 71(6):1570-7. PubMed ID: 26903278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOLLIP inhibits lipid accumulation and the integrated stress response in alveolar macrophages to control Mycobacterium tuberculosis infection.
    Venkatasubramanian S; Plumlee CR; Dill-McFarland KA; Cohen SB; Gern BH; Rane DA; Meyer MK; Saha A; Hinderstein SA; Pearson GL; Lietzke AC; Pacheco A; Chow YH; Hung CF; Soleimanpour SA; Altman M; Urdahl KB; Shah JA
    Nat Microbiol; 2024 Apr; 9(4):949-963. PubMed ID: 38528148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
    Koo MS; Manca C; Yang G; O'Brien P; Sung N; Tsenova L; Subbian S; Fallows D; Muller G; Ehrt S; Kaplan G
    PLoS One; 2011 Feb; 6(2):e17091. PubMed ID: 21364878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
    Ordonez AA; Pokkali S; Kim S; Carr B; Klunk MH; Tong L; Saini V; Chang YS; McKevitt M; Smith V; Gossage DL; Jain SK
    PLoS One; 2018; 13(5):e0197474. PubMed ID: 29758082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis.
    Mourik BC; Leenen PJ; de Knegt GJ; Huizinga R; van der Eerden BC; Wang J; Krois CR; Napoli JL; Bakker-Woudenberg IA; de Steenwinkel JE
    Am J Respir Cell Mol Biol; 2017 Feb; 56(2):233-241. PubMed ID: 27654457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.
    Pienaar E; Cilfone NA; Lin PL; Dartois V; Mattila JT; Butler JR; Flynn JL; Kirschner DE; Linderman JJ
    J Theor Biol; 2015 Feb; 367():166-179. PubMed ID: 25497475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
    Subbian S; Tsenova L; O'Brien P; Yang G; Koo MS; Peixoto B; Fallows D; Dartois V; Muller G; Kaplan G
    PLoS Pathog; 2011 Sep; 7(9):e1002262. PubMed ID: 21949656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques.
    Winchell CG; Mishra BB; Phuah JY; Saqib M; Nelson SJ; Maiello P; Causgrove CM; Ameel CL; Stein B; Borish HJ; White AG; Klein EC; Zimmerman MD; Dartois V; Lin PL; Sassetti CM; Flynn JL
    Front Immunol; 2020; 11():891. PubMed ID: 32477361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
    Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
    mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.